Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism-Reference-Cited by-同舟云学术

Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism

Published:2009-11 Issue:6 Volume:1 Page:552-562
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Dobson Claire L.,Main Sarah,Newton Philip,Chodorge Matthieu,Cadwallader Karen,Humphreys Robin C.,Albert Vivian,Vaughan Tristan J.,Minter Ralph R.,Edwards Bryan M.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.1.6.10057

Reference60 articles.

1. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family

2. Safety and antitumor activity of recombinant soluble Apo2 ligand

3. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

4. The Receptor for the Cytotoxic Ligand TRAIL

5. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gigavalent Display of Proteins on Monodisperse Polyacrylamide Hydrogels as a Versatile Modular Platform for Functional Assays and Protein Engineering;ACS Central Science;2022-08-01

2. Gigavalent display of proteins on monodisperse polyacrylamide hydrogels as a versatile modular platform for functional assays and protein engineering;2021-10-31

3. The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials;Frontiers in Molecular Biosciences;2021-03-10

4. Monoclonal Antibodies as Neurological Therapeutics;Pharmaceuticals;2021-01-26

5. Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action;mAbs;2020-01-01